Literature DB >> 19689273

Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.

Lee Jia1, Yuqing Zhao, Xing-Jie Liang.   

Abstract

This review, a sequel to part 1 in the series, collects about 107 chemical entities separated from the roots, leaves and flower buds of Panax ginseng, quinquefolius and notoginseng, and categorizes these entities into about 18 groups based on their structural similarity. The bioactivities of these chemical entities are described. The 'Yin and Yang' theory and the fundamentals of the 'five elements' applied to the traditional Chinese medicine (TCM) are concisely introduced to help readers understand how ginseng balances the dynamic equilibrium of human physiological processes from the TCM perspectives. This paper concerns the observation and experimental investigation of biological activities of ginseng used in the TCM of past and present cultures. The current biological findings of ginseng and its medical applications are narrated and critically discussed, including 1) its antihyperglycemic effect that may benefit type II diabetics; in vitro and in vivo studies demonstrated protection of ginseng on beta-cells and obese diabetic mouse models. The related clinical trial results are stated. 2) its aphrodisiac effect and cardiovascular effect that partially attribute to ginseng's bioactivity on nitric oxide (NO); 3) its cognitive effect and neuropharmacological effect that are intensively tested in various rat models using purified ginsenosides and show a hope to treat Parkinson's disease (PD); 4) its uses as an adjuvant or immunotherapeutic agent to enhance immune activity, appetite and life quality of cancer patients during their chemotherapy and radiation. Although the apoptotic effect of ginsenosides, especially Rh2, Rg3 and Compound K, on various tumor cells has been shown via different pathways, their clinical effectiveness remains to be tested. This paper also updates the antioxidant, anti-inflammatory, anti-apoptotic and immune-stimulatory activities of ginseng, its ingredients and commercial products, as well as common side effects of ginseng mainly due to its overdose, and its pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19689273      PMCID: PMC2754208          DOI: 10.2174/092986709788803204

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  155 in total

1.  Six new dammarane-type triterpene saponins from the leaves of Panax ginseng.

Authors:  D Q Dou; Y J Chen; L H Liang; F G Pang; N Shimizu; T Takeda
Journal:  Chem Pharm Bull (Tokyo)       Date:  2001-04       Impact factor: 1.645

2.  Probable interaction between warfarin and ginseng.

Authors:  K Janetzky; A P Morreale
Journal:  Am J Health Syst Pharm       Date:  1997-03-15       Impact factor: 2.637

3.  Ginseng therapy in non-insulin-dependent diabetic patients.

Authors:  E A Sotaniemi; E Haapakoski; A Rautio
Journal:  Diabetes Care       Date:  1995-10       Impact factor: 19.112

4.  A pair of 24-hydroperoxyl epimeric dammarane saponins from flower-buds of Panax ginseng.

Authors:  F Qiu; Z Z Ma; S X Xu; X S Yao; C T Che; Y J Chen
Journal:  J Asian Nat Prod Res       Date:  2001       Impact factor: 1.569

5.  A dammarane glycoside derived from ginsenoside Rb3.

Authors:  Kejiang He; Yong Liu; Yi Yang; Peng Li; Ling Yang
Journal:  Chem Pharm Bull (Tokyo)       Date:  2005-02       Impact factor: 1.645

6.  Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng.

Authors:  Robbie Y K Chan; Wen-Fang Chen; Aling Dong; Dean Guo; Man-Sau Wong
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

7.  The phytoestrogen ginsensoside Re activates potassium channels of vascular smooth muscle cells through PI3K/Akt and nitric oxide pathways.

Authors:  Yutaka Nakaya; Kazuaki Mawatari; Akira Takahashi; Nagakatsu Harada; Akiko Hata; Sonoko Yasui
Journal:  J Med Invest       Date:  2007-08

8.  In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria.

Authors:  B H Lee; S J Lee; J H Hur; S Lee; J H Sung; J D Huh; C K Moon; J H Hui
Journal:  Planta Med       Date:  1998-08       Impact factor: 3.352

Review 9.  Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds.

Authors:  S Shibata
Journal:  J Korean Med Sci       Date:  2001-12       Impact factor: 2.153

10.  Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells.

Authors:  H Nakata; Y Kikuchi; T Tode; J Hirata; T Kita; K Ishii; K Kudoh; I Nagata; N Shinomiya
Journal:  Jpn J Cancer Res       Date:  1998-07
View more
  80 in total

1.  A hexane fraction of American ginseng suppresses mouse colitis and associated colon cancer: anti-inflammatory and proapoptotic mechanisms.

Authors:  Deepak Poudyal; Phuong Mai Le; Tia Davis; Anne B Hofseth; Alena Chumanevich; Alexander A Chumanevich; Michael J Wargovich; Mitzi Nagarkatti; Prakash S Nagarkatti; Anthony Windust; Lorne J Hofseth
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-31

2.  Complementary and alternative medicine for the treatment of multiple sclerosis.

Authors:  Vijayshree Yadav; Lynne Shinto; Dennis Bourdette
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

3.  Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.

Authors:  M Endale; W M Lee; S M Kamruzzaman; S D Kim; J Y Park; M H Park; T Y Park; H J Park; J Y Cho; M H Rhee
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 4.  Therapeutic potential of ginseng in the management of cardiovascular disorders.

Authors:  Morris Karmazyn; Melissa Moey; Xiaohong Tracey Gan
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

Review 5.  Potential neuroprotective activity of Ginseng in Parkinson's disease: a review.

Authors:  Elena González-Burgos; Carlos Fernandez-Moriano; M Pilar Gómez-Serranillos
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-29       Impact factor: 4.147

6.  Ginsenosides from Korean red ginseng modulate T cell function via the regulation of NF-AT-mediated IL-2 production.

Authors:  Le Ba Vinh; Jung Up Park; Le Xuan Duy; Nguyen Thi Minh Nguyet; Seo Young Yang; Young Ran Kim; Young Ho Kim
Journal:  Food Sci Biotechnol       Date:  2018-07-11       Impact factor: 2.391

Review 7.  Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension.

Authors:  Morris Karmazyn; Xiaohong Tracey Gan
Journal:  Mol Cell Biochem       Date:  2020-09-17       Impact factor: 3.396

8.  Ginsenoside Rg3 inhibits CXCR4 expression and related migrations in a breast cancer cell line.

Authors:  Xiao-Ping Chen; Lin-Lin Qian; Hong Jiang; Jiang-Hua Chen
Journal:  Int J Clin Oncol       Date:  2011-04-01       Impact factor: 3.402

9.  Ginsenoside Rg3 inhibits HIF-1α and VEGF expression in patient with acute leukemia via inhibiting the activation of PI3K/Akt and ERK1/2 pathways.

Authors:  Dongfeng Zeng; Jinliang Wang; Peiyan Kong; Cheng Chang; Jieping Li; Jiali Li
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

10.  Therapeutic potential of compound K as an IKK inhibitor with implications for osteoarthritis prevention: an in silico and in vitro study.

Authors:  Sera Kang; Muhammad Hanif Siddiqi; Sung Joo Yoon; Sungeun Ahn; Hae-Yong Noh; Natarajan Sathish Kumar; Yeon-Ju Kim; Deok-Chun Yang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-07-01       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.